A Whole-Cell Catalytic System for Equol Production Based on Daidzein Reductase Engineering
Molecules · 2026
DOI: 10.3390/molecules31040711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Bing-Juan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Food and Biotechnology, Department of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China. Hauptthemen laut MEDLINE: Equol, Isoflavones, Protein Engineering, Oxidoreductases. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
As an isoflavone metabolite with diverse physiological activities, the development of efficient and sustainable manufacturing technologies for (S)-equol holds significant importance. This study focuses on the semi-rational design of daidzein reductase (DZNR), the first key enzyme in the (S)-equol biotransformation pathway. Through multiple sequence alignment and three-dimensional structural analysis, two critical residues, Gly30 and Ala105, were identified in DZNR. A library of single and combinatorial mutants was constructed and screened, yielding the double variant DZNR30S+105S with substantially enhanced catalytic performance. In a whole-cell biocatalytic system, the recombinant E. coli (Escherichia coli) strain harboring this combinatorial mutant achieved a yield of 238.3 mg/L (S)-equol at a substrate concentration of 1 mM daidzein, demonstrating markedly improved catalytic efficiency. Upon increasing the daidzein concentration to 2 mM, the reaction reached equilibrium within 5 h, producing 384.6 mg/L (S)-equol, which highlights the mutant’s excellent potential for high-substrate-concentration applications. This study not only provides novel mechanistic insights into DZNR catalysis but also successfully establishes a DZNR variant with enhanced activity, offering an efficient biocatalytic component for the industrial-scale biomanufacturing of (S)-equol and thereby advancing the development of green biosynthesis technologies for this valuable compound.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Key Laboratory of Food and Biotechnology, Department of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China.
ORCID-Profile: Bing-Juan Li, Jiao-Jiao Zhuo, Hong-Yan Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, B. J., Zhuo, J. J., Tian, M. R., Meng, D., & Li, H. Y. (2026). A Whole-Cell Catalytic System for Equol Production Based on Daidzein Reductase Engineering. Molecules. https://doi.org/10.3390/molecules31040711
Vancouver
Li BJ, Zhuo JJ, Tian MR, Meng D, Li HY. A Whole-Cell Catalytic System for Equol Production Based on Daidzein Reductase Engineering. Molecules. 2026. doi:10.3390/molecules31040711
BibTeX
@article{Li2026,
author = {Li, Bing-Juan and Zhuo, Jiao-Jiao and Tian, Meng-Ran and Meng, Dan and Li, Hong-Yan},
title = {A Whole-Cell Catalytic System for Equol Production Based on Daidzein Reductase Engineering},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31040711}
}
EUVIMED